Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection

Imagem de Miniatura
Arquivos
art_TEIXEIRA JR._Leiomyosarcoma_of_the_inferior_vena_cava_Survival_rate_2017.PDF (1.55 MB)
Citações na Scopus
41
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPANDIDOS PUBL LTD
Autores
Citação
ONCOLOGY LETTERS, v.14, n.4, p.3909-3916, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Leiomyosarcoma (LMS) of inferior vena cava (IVC) is a rare neoplasm affecting approximately 1/100,000 people. The prognosis is poor and potential curative intent occurs through challenging operations, such as vena cava resection, occasionally multivisceral when required, and vascular reconstruction. There are few retrospective series regarding this retroperitoneal neoplasm, and the aim of the present study was to discuss the experience at the Sao Paulo Cancer Institute and Clinics Hospital of University of Sao Paulo Medical School, Sao Paulo, Brazil. The current study is a retrospective review of 7 patients treated in the two tertiary hospitals between 2005 and 2013. Oncological and operative aspects were discussed, primarily regarding surgical aspects highlighting en bloc resection, vascular reconstruction, and the overall survival and recurrence rates. All the patients were treated with radical intent, 4 of whom underwent multivisceral resection, with the kidney being the most resected organ. The location of the IVC tumor was described using Kulaylat's description and the median tumor size was 10 cm. Vascular reconstruction was necessary in 4 patients. The overall survival rate at 3 and 5 years was 100, and 25%, respectively. The disease-free survival rate at 3 and 5 years was 57 and 20%, respectively. In conclusion, IVC LMS is a rare and severe retroperitoneal neoplasm, with multivisceral resections remaining a surgical challenge. The treatment requires numerous experienced surgeons and the impact of microscopic free margins remains unclear. Vascular reconstruction depends on several aspects regarding primarily the topography of the tumor.
Palavras-chave
leiomyosarcoma, inferior vena cava sarcoma, retroperitoneal sarcoma, retroperitoneal tumor, sarcoma, vena cava tumor
URI
https://observatorio.fm.usp.br/handle/OPI/24176
Referências
  1. Angiletta D, 2011, ANN VASC SURG, V25, DOI 10.1016/j.avsg.2010.12.015
  2. Arkadopoulos N, 2012, SURGERY, V152, P142, DOI 10.1016/j.surg.2012.03.007
  3. Bower TC, 2000, J VASC SURG, V31, P270, DOI 10.1016/S0741-5214(00)90158-7
  4. CACOUB P, 1991, MEDICINE, V70, P293, DOI 10.1097/00005792-199109000-00002
  5. Chen E, 2011, HISTOPATHOLOGY, V59, P1135, DOI 10.1111/j.1365-2559.2011.04070.x
  6. COPE JS, 1954, AMA ARCH SURG, V68, P752
  7. Daylami R, 2010, J AM COLL SURGEONS, V210, P185, DOI 10.1016/j.jamcollsurg.2009.10.010
  8. Dew J, 2005, AM SURGEON, V71, P497
  9. Gronchi A, 2012, ANN ONCOL, V23, P1067, DOI 10.1093/annonc/mdr323
  10. Hardwigsen J, 2005, J AM COLL SURGEONS, V200, P57, DOI 10.1016/j.jamcollsurg.2004.09.035
  11. Hardwigsen J, 2001, ANN SURG, V233, P242, DOI 10.1097/00000658-200102000-00014
  12. Hines OJ, 1999, CANCER, V85, P1077, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1077::AID-CNCR10>3.0.CO;2-0
  13. Hollenbeck ST, 2003, J AM COLL SURGEONS, V197, P575, DOI 10.1016/S1072-7515(03)00433-2
  14. Illuminati G, 2006, ARCH SURG-CHICAGO, V141, P919, DOI 10.1001/archsurg.141.9.919
  15. Ito H, 2007, ANN SURG ONCOL, V14, P3534, DOI 10.1245/s10434-007-9552-z
  16. KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
  17. Kieffer E, 2006, ANN SURG, V244, P289, DOI 10.1097/01.sla.0000229964.71743.db
  18. Kim JT, 2012, J KOREAN SURG SOC, V82, P101, DOI 10.4174/jkss.2012.82.2.101
  19. Kraybill WG, 1997, SURGERY, V121, P31, DOI 10.1016/S0039-6060(97)90179-3
  20. Kulaylat MN, 1997, J SURG ONCOL, V65, P205, DOI 10.1002/(SICI)1096-9098(199707)65:3<205::AID-JSO11>3.0.CO;2-2
  21. Kwon TW, 2003, J KOREAN MED SCI, V18, P355
  22. Laskin WB, 2010, AM J SURG PATHOL, V34, P873, DOI 10.1097/PAS.0b013e3181ddf569
  23. Mann GN, 2012, SURGERY, V151, P261, DOI 10.1016/j.surg.2010.10.011
  24. Mastoraki A, 2015, INT J SURG, V13, P92, DOI 10.1016/j.ijsu.2014.11.051
  25. Mingoli A, 1996, ANTICANCER RES, V16, P3201
  26. Perl L, 1871, VIRCHOWS ARCH A, V53, P378, DOI 10.1007/BF01957198
  27. Quinones-Baldrich W, 2012, J VASC SURG, V55, P1386, DOI 10.1016/j.jvs.2011.11.054
  28. Ramponi F, 2012, J VASC SURG, V55, P525, DOI 10.1016/j.jvs.2011.06.112
  29. Sarkar R, 1998, J VASC SURG, V28, P75, DOI 10.1016/S0741-5214(98)70202-2
  30. Serrano C, 2013, HEMATOL ONCOL CLIN N, V27, P957, DOI 10.1016/j.hoc.2013.07.002
  31. Toulmonde M, 2014, ANN ONCOL, V25, P735, DOI 10.1093/annonc/mdt577
  32. TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108
  33. Wachtel H, 2015, SURG ONCOL, V24, P21, DOI 10.1016/j.suronc.2014.10.007
  34. Wachtel H, 2015, J SURG ONCOL, V111, P328, DOI 10.1002/jso.23798
  35. Wang Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-120
  36. Yamaguchi R, 1998, SURG TODAY, V28, P359

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/02
Artigos e Materiais de Revistas Científicas - LIM/55
Artigos e Materiais de Revistas Científicas - LIM/62
Carregar mais